Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

Recruiting N/A Interventional Study
Macular Degeneration, Senile Laser Burn of Retina Macular Degeneration Intermediate Macular Degeneration, Dry
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
Ospedale San Raffaele · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Prospective, randomized, controlled, longitudinal, interventional multicentric study involving patients with reticular pseudodrusen secondary to AMD. The objective of this study is to establish the effectiveness of subthreshold laser treatment in increase/prevent the decrease of the retinal sensibility in patients with reticular pseudodrusen, and to reduce the progression of RPD to atrophy. Appr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 50 years or older * Presence of RPD secondary to AMD * Best-corrected visual acuity (BCVA) between 20/20 and 20/400 inclusive * Clear ocular media * Ability to provide informed consent and attend all study visits Exclusion Criteria: * Presence of Geographic Atrophy (GA) * Ev…
Contacts

Giuseppe Querques, MD, PhD

+390226434004

querques.giuseppe@hsr.it

CONTACT